MeSH Browser

MeSH Supplementary: dolutegravir
Unique ID: C562325
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C562325
Entry Term(s): (4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide; (4R,9aS)-5-hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid- 2,4 difluorobenzylamide; (4S,12aR)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide; (4S,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide; GSK 1349572A; GSK-1349572; GSK-1349572A; GSK1349572A; S-GSK1349572; Tivicay; Tivicay PD; dolutegravir S,R isomer; dolutegravir S,S-isomer; dolutegravir sodium; dolutegravir sodium monohydrate
Pharm Action: HIV Integrase Inhibitors
Registry Numbers: DKO1W9H7M1; 0; 1Q1V9V5WYQ; 0E1T06685X; S3BN9Q9EHW; FGD6SPP2VH
Related Numbers: 0E1T06685X; 1Q1V9V5WYQ; FGD6SPP2VH; S3BN9Q9EHW
Heading Mapped to: *Heterocyclic Compounds, 3-Ring; *Oxazines; *Piperazines; *Pyridones
Frequency: 1018
Note: an HIV-1 integrase inhibitor
Source: Antimicrob Agents Chemother 2010 Jan;54(1):254-8
Date of Entry: 2011/11/13
Revision Date: 2022/08/10

dolutegravir MeSH Supplementary Concept Data 2025